http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-039880-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c2b978c76fe00549ac2effe53f6a3e85
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
filingDate 2018-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_489c2b1bf7a3e27d6d71cc402adb1a16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4aa4904dfbf769d8ab8cad4dfda808af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bafb4d29ad9b25fd09aa1d3a6707550
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_afb34aaaf2b5366ba9b402115f2d749a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f782d3dfa241c6114c813afbafefdc66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdb5059abc56d265db6b9300bdbbf766
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_801f313ee4fab1502c3dd879f675e051
publicationDate 2022-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-039880-B1
titleOfInvention METHOD FOR OBTAINING OPTICALLY ACTIVE COMPOUND
abstract The purpose of the invention is to provide a process for obtaining an optically active pyrimidinamide derivative on an industrial scale. Compound (I) or a salt thereof is subjected to an asymmetric reduction reaction, the resulting compound (II) or a salt thereof is subjected to a deprotonation reaction, and the resulting compound (III) or a salt thereof is reacted with a compound (IV) or a salt thereof to obtain a compound (V) or salts thereof, wherein each symbol is as defined in the description of the present invention.
priorityDate 2017-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7968536-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9556177-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7709500-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421359150
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15149799

Total number of triples: 24.